Shaker A. Mousa
14Patents
4h-index
7Co-inventors
49Inventor score
Filing activity: Mar 10, 2000 → Nov 2, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6346517B1 | Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders | Human Necessities | 8 | Expired |
| US6284726A | Inhibition of angiogenesis by peptide analogs of high molecular weight kininogen domain 5 | Human Necessities | 6 | Expired |
| US7964338B2 | Platelet preservation composition containing eptifibatide, a reversible factor IIa inhibitor and a hemoglobin oxygen carrier | Human Necessities | 6 | Active |
| US8142992B2 | Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier | Human Necessities | 4 | Active |
| US8563053B2 | Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis | Chemistry; Metallurgy | 4 | Active |
| US8129104B2 | Platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with hemoglobin | Human Necessities | 3 | Active |
| US8129103B2 | Use of a platelet preservation composition comprising a short to ultra-short acting antiplatelet agent and anticoagulant with an oxygen carrier | Human Necessities | 2 | Active |
| US6994852B1 | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 | Chemistry; Metallurgy | 1 | Expired |
| US9700042B2 | Nanoformulation of musk-derived bioactive ingredients for nanocosmetic applications | Human Necessities | 0 | Active |
| US9572831B2 | Composition and method for sulfated non-anticoagulant low molecular weight heparins in cancer and tumor metastasis | Human Necessities | 0 | Active |
| US9707318B2 | Compositions of novel bone patch in bone and vascular regeneration | Human Necessities | 0 | Active |
| US7332161B2 | Treatment of disease with antibodies against high molecular weight kininogen domain 5 | Chemistry; Metallurgy | 0 | Expired |
| US9956181B2 | Composition of nanoformulated lycopene and method of using the composition | Human Necessities | 0 | Active |
| US10251842B1 | Nanocapsule containing a bioactive compound, and a method of reducing toxicity resulting from cancer therapy | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.